Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Neoplasms × Propofol × Clear all

Phase

Status

Completed 9 Recruiting 2 Active not recruiting 2 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Postoperative Complications 1 Neoplasms 1 Leukemia 1 Endometrial Neoplasms 1 Brain Neoplasms 1 Agnosia 1

Interventions

Cisplatin 9 pembrolizumab 5 Radiosurgery 5 Gemcitabine 5 Taxes 4 Paclitaxel 4 Dexamethasone 4 trametinib 3 ibrutinib 3 Surveys and Questionnaires 3 Standard of Care 3 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Fluorouracil 3 Carboplatin 3 Ascorbic Acid 3 tocilizumab 2 pazopanib 2 obinutuzumab 2 naquotinib 2 lenvatinib 2 fludarabine 2 enzalutamide 2 Trastuzumab 2 Surgical Procedures, Operative 2 SS1(dsFv)PE38 2 Radiation Dose Hypofractionation 2 Pemetrexed 2 Ondansetron 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00531349 2016-05-09

ECA/R

The Cleveland Clinic

Phase 3 Withdrawn

Agnosia, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡